Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice. [Review] (Record no. 4175)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01808nam a22003017a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201229s20172017 xxu||||| |||| 00| 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 2364-768X |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | Ovid MEDLINE(R) |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) | |
PMID | 30911634 |
245 ## - TITLE STATEMENT | |
Title | Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice. [Review] |
251 ## - Source | |
Source | Pleura and Peritoneum. 2(2):63-72, 2017 Jun 01. |
252 ## - Abbreviated Source | |
Abbreviated source | Pleura Peritoneum. 2(2):63-72, 2017 Jun 01. |
253 ## - Journal Name | |
Journal name | Pleura and peritoneum |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Year | 2017 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Manufacturer | FY2017 |
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] | |
Publication status | ppublish |
266 ## - Date added to catalog | |
Date added to catalog | 2020-12-29 |
520 ## - SUMMARY, ETC. | |
Abstract | Peritoneal surface malignancy (PSM) is a common manifestation of digestive and gynecologic malignancies alike. At present, patients with isolated PSM are treated with a combination therapy of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). The combination of CRS and intraperitoneal (IP) chemotherapy should now be considered standard of care for PSM from appendiceal epithelial cancers, colorectal cancer and peritoneal mesothelioma. Although there is a near universal standardization regarding the CRS, we are still lacking a much-needed standardization among the various IP chemotherapy treatment modalities used today in clinical practice. Pharmacologic evidence should be generated to answer important questions raised by the myriad of variables associated with IP chemotherapy. |
546 ## - LANGUAGE NOTE | |
Language note | English |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | IN PROCESS -- NOT YET INDEXED |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME | |
Institution | Washington Cancer Institute |
657 ## - INDEX TERM--FUNCTION | |
Medline publication type | Journal Article |
657 ## - INDEX TERM--FUNCTION | |
Medline publication type | Review |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Local Authors | Sugarbaker, Paul H |
790 ## - Authors | |
All authors | Lemoine L, Sugarbaker P, Van der Speeten K |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
DOI | <a href="https://dx.doi.org/10.1515/pp-2017-0003">https://dx.doi.org/10.1515/pp-2017-0003</a> |
Public note | https://dx.doi.org/10.1515/pp-2017-0003 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Koha item type | Journal Article |
Item type description | Article |
Withdrawn status | Lost status | Damaged status | Not for loan | Collection | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MedStar Authors Catalog | MedStar Authors Catalog | 12/29/2020 | 30911634 | 30911634 | 12/29/2020 | 12/29/2020 | Journal Article |